TechNavio’s analysts forecast the Global Stem Cell Products market to grow at a CAGR of 12.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements in R&D. The Global Stem Cell Products market has also been witnessing new regulations for regenerative medicine in the EMEA region. However, the lack of specialists in this domain could pose a challenge to the growth of this market.
TechNavio’s report, Global Stem Cell Products Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Stem Cell Products market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Baxter International Inc., DePuy Inc., Medtronic Inc., Stryker Corp., and Zimmer Holdings Inc.
The other vendors mentioned in the report are 3DM Inc., Aastrom Biosciences Inc., Advanced Cell Technology Inc., Aldagen Inc., Angioblast Systems Inc., Arteriocyte Inc., Athersys Inc., BioE Corp., Bioheart Inc., BioTime Inc., Brainstorm Cell Therapeutics Inc., Capricor Inc., Cardio3 BioSciences SA, Cellartis AB, Cellerant Therapeutics Inc., Cellular Dynamics International Inc., Cytori Therapeutics Inc., Forticell Bioscience Inc., Gamida Cell Ltd., GlobalStem Inc., Hybrid Organ GmbH, IntelliCell BioSciences Inc., International Stem Cell Corp., Juventas Therapeutics Inc., Medistem Inc., Mesoblast Ltd., NeoStem Inc., Neuralstem Inc., Osiris Therapeutics Inc., PharmaStem Therapeutics Inc., Plureon Corp., ReNeuron Group plc, RhinoCyte Inc., StemCells Inc., Stemcell Technologies SARL, Stem Cell Therapeutics Corp., Stemedica Cell Technologies Inc., Stemina Biomarker Discovery Inc., TiGenix NV, Verastem Inc., ViaCyte Inc., and Vitro Diagnostics Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of each of these key vendors?
1. Executive Summary
2. List of Abbreviations
4. Research Methodology
5. Market Coverage
6. Market Landscape
6.1. Market Size
6.2. Market Forecast
6.3. Five Force Analysis
7. Geographical Segmentation
8. Key Leading Countries
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1. Baxter International Inc.
16.1.1. Business Overview
16.1.2. Business Segmentation
16.1.3. SWOT Analysis
16.2. DePuy Inc.
16.2.1. Business Overview
16.2.2. Business Segmentation
16.2.3. Key Information
16.2.4. SWOT Analysis
16.3. Medtronic Inc.
16.3.1. Business Overview
16.3.2. Business Segmentation
16.3.3. SWOT Analysis
16.4. Stryker Corp.
16.4.1. Business Overview
16.4.2. Business Segmentation
16.4.3. Key Information
16.4.4. SWOT Analysis
16.5. Zimmer Holdings Inc.
16.5.1. Business Overview
16.5.2. Business Segmentation
16.5.3. Key Information
16.5.4. SWOT Analysis
17. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Stem Cell Products Market 2012–2016 (US$ billion)
Exhibit 2: Stem Cell Products Market in the Americas 2012–2016 (US$ billion)
Exhibit 3: Stem Cell Products Market in the APAC Region 2012–2016 (US$ billion)
Exhibit 4: Stem Cell Products Market in the EMEA Region 2012–2016 (US$ billion)
Exhibit 5: Global Stem Cell Products Market by Geographical Segmentation 2012
Exhibit 6: Business Segmentation of Baxter International Inc.
Exhibit 7: Business Segmentation of DePuy Inc.
Exhibit 8: Business Segmentation of Medtronic Inc.
Exhibit 9: Business Segmentation of Stryker Corp.
Exhibit 10: Business Segmentation of Zimmer Holdings Inc.